BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27163757)

  • 1. Interferon Gamma and Contact-dependent Cytotoxicity Are Each Rate Limiting for Natural Killer Cell-Mediated Antibody-dependent Chronic Rejection.
    Lin CM; Plenter RJ; Coulombe M; Gill RG
    Am J Transplant; 2016 Nov; 16(11):3121-3130. PubMed ID: 27163757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation.
    Lin CM; Gill RG; Mehrad B
    Am J Transplant; 2021 Nov; 21(11):3550-3560. PubMed ID: 34014614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute cardiac allograft rejection by directly cytotoxic CD4 T cells: parallel requirements for Fas and perforin.
    Grazia TJ; Plenter RJ; Weber SM; Lepper HM; Victorino F; Zamora MR; Pietra BA; Gill RG
    Transplantation; 2010 Jan; 89(1):33-9. PubMed ID: 20061916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet allograft rejection by contact-dependent CD8+ T cells: perforin and FasL play alternate but obligatory roles.
    Sleater M; Diamond AS; Gill RG
    Am J Transplant; 2007 Aug; 7(8):1927-33. PubMed ID: 17617855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
    Taylor MA; Ward B; Schatzle JD; Bennett M
    Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of effector mechanisms in murine cardiac allograft rejection.
    Alexander DZ; Pearson TC; Hendrix R; Ritchie SC; Larsen CP
    Transpl Immunol; 1996 Mar; 4(1):46-8. PubMed ID: 8762009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing.
    Komatsu M; Mammolenti M; Jones M; Jurecic R; Sayers TJ; Levy RB
    Blood; 2003 May; 101(10):3991-9. PubMed ID: 12521999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells play a critical role in cardiac allograft vasculopathy in an interleukin-6--dependent manner.
    Zhang ZX; Huang X; Jiang J; Lian D; Min WP; Liu W; Haig A; Jevnikar AM
    Transplantation; 2014 Nov; 98(10):1029-39. PubMed ID: 25286056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
    Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An essential contribution by IFN-gamma to CD8+ T cell-mediated rejection of pancreatic islet allografts.
    Diamond AS; Gill RG
    J Immunol; 2000 Jul; 165(1):247-55. PubMed ID: 10861058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8 lymphocytes are sufficient for the development of chronic rejection.
    Schnickel GT; Whiting D; Hsieh GR; Yun JJ; Fischbein MP; Fishbein MC; Yao W; Shfizadeh A; Ardehali A
    Transplantation; 2004 Dec; 78(11):1634-9. PubMed ID: 15591952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
    Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
    Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
    J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
    Austin Taylor M; Bennett M; Kumar V; Schatzle JD
    J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ T cells mediate aortic allograft vasculopathy by direct killing and an interferon-gamma-dependent indirect pathway.
    Skaro AI; Liwski RS; Zhou J; Vessie EL; Lee TD; Hirsch GM
    Cardiovasc Res; 2005 Jan; 65(1):283-91. PubMed ID: 15621057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cells promote peritoneal xenograft rejection through an IFN-gamma-dependent mechanism.
    Lin ML; Zhan Y; Nutt SL; Brady J; Wojtasiak M; Brooks AG; Lew AM
    Xenotransplantation; 2006 Nov; 13(6):536-46. PubMed ID: 17059581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine and cytotoxic pathways of NK cell rejection of class I-deficient bone marrow grafts: influence of mouse colony environment.
    Bennett M; Taylor PA; Austin M; Baker MB; Schook LB; Rutherford M; Kumar V; Podack ER; Mohler KM; Levy RB; Blazar BR
    Int Immunol; 1998 Jun; 10(6):785-90. PubMed ID: 9678759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody.
    Hirohashi T; Chase CM; Della Pelle P; Sebastian D; Alessandrini A; Madsen JC; Russell PS; Colvin RB
    Am J Transplant; 2012 Feb; 12(2):313-21. PubMed ID: 22070565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal allograft rejection: protection of renal epithelium from natural killer cells by cytokine-induced up-regulation of class I major histocompatibility antigens.
    Lin Y; Proud G; Taylor RM; Kirby JA
    Immunology; 1993 Jun; 79(2):290-7. PubMed ID: 8344707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.